This site uses cookies to bring you the best experience. Find out more
Skip to main content

News

Find Out The Latest

You can keep in touch with exciting developments for The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also keep up to date by following us on Twitter or LinkedIn  


Moa Technology wins World Economic Forum award

Moa Technology wins World Economic Forum award for research tackling herbicide-resistant weeds that pose a global threat to food security ‍·      Moa uses the kind of biotechnology applied to human health in the critically important field of agriculture ·      It has been selected as a Top Innovator in the Smarter Climate Farmers Challenge run by UpLink, the World Economic Forum’s open innovation platform ·      Moa will receive... Read more

Ellison Institute Expands Planned Oxford Campus

Additional property acquisition, part of The Oxford Science Park, is adjacent to the recently purchased Littlemore House OXFORD, U.K. – The Lawrence J. Ellison Institute for Transformative Medicine is adding to its planned Oxford scientific campus, which will be a permanent home to research laboratories, a patient clinic, educational facilities, and collaborative spaces in support of the Ellison Institute’s research and healthcare... Read more

Ellison Institute of Technology joins The Oxford Science Park

The Ellison Institute of Technology has unveiled its project for the Oxford Campus, situated at The Oxford Science Park (click link to find out more). This campus will bring together innovative thinkers from around the world to support the Ellison Institute of Technology (EIT)’s mission of solving some of humanity’s most challenging and enduring problems. The Oxford Science Park is excited to be part of this endeavour. More information... Read more

Oxford Bio Therapeutics relocates UK Headquarters to strategic and cutting-edge R&D location at The Oxford Science Park

Oxford, UK and San Jose, Calif., 11 October 2023 Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate (ADC)-based therapies, today announced that it has relocated its UK headquarters to The Schrodinger Building within The Oxford Science Park. The new facilities comprise state-of-the-art office and custom laboratory spaces that will support and enhance OBT’s growing... Read more

The Iversen Building

On Wednesday, the 27th of September, The Oxford Science Park was delighted to host the opening of the latest and hugely exciting addition to its portfolio: the Iversen Building. This new 88,000 sq ft NIA lab-ready facility expands the Park's total area by almost 20% and significantly increases its capacity for high-quality laboratories.  The Iversen Building is the largest and most advanced spec-built commercial science building in Oxfordshire... Read more